首页> 外文期刊>Journal of radiation research >An easy and novel method for safer brachytherapy: real-time fluoroscopic verification of high-dose-rate 192Ir source position using a flat-panel detector
【24h】

An easy and novel method for safer brachytherapy: real-time fluoroscopic verification of high-dose-rate 192Ir source position using a flat-panel detector

机译:一种简单而新颖的方法,用于更安全的近距离放射治疗:使用平板探测器的高剂量率192ir源位置的实时荧光透视验证

获取原文
           

摘要

Real-time fluoroscopic verification of the active source position during actual treatment is the only established method to prevent high-dose-rate (HDR) brachytherapy events. The challenge is spurious signals from an HDR 192Ir source that result in image halation, making source positions indiscernible when using a non-modified image intensifier fluoroscope. We have previously reported a method for observing an HDR 192Ir source by using an elaborately modified image intensifier system. The newly developed flat-panel detector fluoroscope is, by contrast, inherently halation-free thanks to the wider dynamic range (12–14 bits), compared with image intensifier fluoroscopes (8 bits). To explore the feasibility, we applied a commercially available flat-panel detector fluoroscope without modification to actual treatment. We successfully observed source positions without halation for all 107 patients, with a total of 522 HDR treatment sessions during a 3-year period from 2014 to 2017. Actual source positions were compared with planned positions on the planning hard copy. With this method, we detected a total of 1 error (0.2%) among the 522 sessions, at a similar detection rate of 0.1% with our previous experience using a modified image intensifier fluoroscope. We found that a commercially available flat-panel detector fluoroscope is ready for use for real-time verification and outweighs the need for elaborate modifications of an image intensifier fluoroscope. A flat-panel detector fluoroscope will help the global radiation oncology community promote real-time verification programs, leading to safer HDR brachytherapy.
机译:实际治疗期间有源源位置的实时荧光透视验证是预防高剂量率(HDR)近距离放射治疗事件的唯一建立的方法。挑战是来自HDR 192IR源的杂散信号,导致图像光晕,在使用非修改的图像增强器荧光镜时使源位置无法辨认。我们之前通过使用精心修改的图像增强器系统报告了一种用于观察HDR 192IR源的方法。相比之下,新开发的平板探测器荧光镜具有较宽的动态范围(12-14位),与图像增强器荧光镜(8位)相比,自然无光晕。为了探讨可行性,我们将商业上可用的平板探测器荧光镜应用于实际处理而不改变。我们在2014年至2017年的3年期间成功地观察了所有107名患者的源头,总共有522个HDR治疗课程。将实际的源地位与计划核算的规划职位进行比较。通过这种方法,在522个会话中,我们在522个会话中检测到了1个错误(0.2%),并且在使用经过改进的图像增强器荧光镜的经验之前,类似的检出率为0.1%。我们发现,市售的平板探测器荧光镜准备用于实时验证,并且超过了图像增强器荧光镜的精细修改的需要。平板探测器荧光镜将有助于全球辐射肿瘤学社区促进实时验证计划,导致更安全的HDR近距离放射治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号